Andrew is the Chief Executive of Bioplatforms Australia, overseer of $300 million Commonwealth Government research infrastructure investment in the discovery sciences of genomics, proteomics and metabolomics. With 17 investments across Australia, Andrew has an extensive network of contacts from Commonwealth and State Governments, along with prominent universities, medical research institutes, agricultural research institutes and commercial entities. The network supports 3000 users per annum across the spectrum of pure research to commercial production.

In addition to managing the national infrastructure network, Bioplatforms Australia has catalysed the formation of a series of strategic national scientific collaborations – in the broad themes of agriculture, biodiversity and biomedical science. Each Bioplatforms initiative is by design multi-disciplinary, multi-institutional and contain both discovery implications and pathways to end use. Innovation is inherent in both the model of collaboration and the environment created to foster excellent science and application to national challenges.